Oncotarget. 2010 Jul;1(3):163-6.

Phosphatidylcholine metabolic transformation and progression signature as a pharmacodynamic biomarker.

Source

Comprehensive Cancer Imaging Centre, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. eric.aboagye@imperial.ac.uk

Comment on

Oncotarget. 2010 Jul;1(3):185-97.

PMID:: 21301046; [PubMed - indexed for MEDLINE]
PMCID:: PMC3157722

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances

Publication Types

Comment

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Save items

Related citations in PubMed

Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition. [Oncotarget. 2010]
Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.
Beloueche-Babari M, Arunan V, Jackson LE, Perusinghe N, Sharp SY, Workman P, Leach MO. Oncotarget. 2010 Jul; 1(3):185-97.
Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer. [BMC Med Genomics. 2010]
Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.
Zajac M, Gomez G, Benitez J, Martínez-Delgado B. BMC Med Genomics. 2010 Oct 4; 3:44. Epub 2010 Oct 4.
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. [Invest New Drugs. 2012]
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.
Pacey S, Gore M, Chao D, Banerji U, Larkin J, Sarker S, Owen K, Asad Y, Raynaud F, Walton M, et al. Invest New Drugs. 2012 Feb; 30(1):341-9. Epub 2010 Aug 5.
Review Targeting Hsp90: small-molecule inhibitors and their clinical development. [Curr Opin Pharmacol. 2008]
Review Targeting Hsp90: small-molecule inhibitors and their clinical development.
Taldone T, Gozman A, Maharaj R, Chiosis G. Curr Opin Pharmacol. 2008 Aug; 8(4):370-4. Epub 2008 Jul 31.
Review Inhibitors of the HSP90 molecular chaperone: current status. [Adv Cancer Res. 2006]
Review Inhibitors of the HSP90 molecular chaperone: current status.
Sharp S, Workman P. Adv Cancer Res. 2006; 95:323-48.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Phosphatidylcholine metabolic transformation and progression signature as a phar...
Phosphatidylcholine metabolic transformation and progression signature as a pharmacodynamic biomarker.
Oncotarget. 2010 Jul ;1(3):163-6.

PubMed
Art in oncology: how patients add life to their days.
Art in oncology: how patients add life to their days.
J Clin Oncol. 2011 Apr 1 ;29(10):1392-3. Epub 2011 Feb 7 .

PubMed
Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall...
Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism.
J Immunol. 2011 Mar 15 ;186(6):3735-44. Epub 2011 Feb 7 .

PubMed
Ncb5or deficiency increases fatty acid catabolism and oxidative stress.
Ncb5or deficiency increases fatty acid catabolism and oxidative stress.
J Biol Chem. 2011 Apr 1 ;286(13):11141-54. Epub 2011 Feb 7 .

PubMed
The cluster 1 type VI secretion system is a major virulence determinant in Burkh...
The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.
Infect Immun. 2011 Apr ;79(4):1512-25. Epub 2011 Feb 7 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: